These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 28727946

  • 1. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    Bhushan A, Ghosh S, Bhattacharjee S, Chinnaswamy S.
    J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
    [Abstract] [Full Text] [Related]

  • 2. Identifying causal variants at the interferon lambda locus in case-control studies: Utilizing non-synonymous variant rs117648444 to probe the role of IFN-λ4.
    Bhushan A, Chinnaswamy S.
    Gene; 2018 Jul 20; 664():168-180. PubMed ID: 29705128
    [Abstract] [Full Text] [Related]

  • 3. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
    Galmozzi E, Facchetti F, Grossi G, Loglio A, Viganò M, Lunghi G, Colombo M, Lampertico P.
    Liver Int; 2018 Mar 20; 38(3):417-423. PubMed ID: 28732143
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C.
    Świątek-Kościelna B, Kałużna E, Strauss E, Nowak J, Bereszyńska I, Gowin E, Wysocki J, Rembowska J, Barcińska D, Mozer-Lisewska I, Januszkiewicz-Lewandowska D.
    World J Gastroenterol; 2017 Jun 07; 23(21):3815-3824. PubMed ID: 28638221
    [Abstract] [Full Text] [Related]

  • 5. Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.
    Lu YF, Goldstein DB, Urban TJ, Bradrick SS.
    Virology; 2015 Feb 07; 476():334-340. PubMed ID: 25577150
    [Abstract] [Full Text] [Related]

  • 6. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR, Pfeiffer RM, Paquin A, Lang Kuhs KA, Chen S, Bonkovsky HL, Edlin BR, Howell CD, Kirk GD, Kuniholm MH, Morgan TR, Strickler HD, Thomas DL, Prokunina-Olsson L.
    J Hepatol; 2015 Nov 07; 63(5):1103-10. PubMed ID: 26186989
    [Abstract] [Full Text] [Related]

  • 7. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
    Wiegand SB, Heidrich B, Susser S, Rogalska-Taranta M, Petersen J, Böker KH, Grigorian N, Link R, Naumann U, John C, Lueth S, Malfertheiner P, Manns MP, Wedemeyer H, Sarrazin C, Cornberg M.
    PLoS One; 2015 Nov 07; 10(12):e0145622. PubMed ID: 26699619
    [Abstract] [Full Text] [Related]

  • 8. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F, Ghazanfari M, Vaziri F, Jamnani FR, Davari M, Gharibzadeh S, Fateh R, Abdolrahimi F, Dizaji SP, Fateh A, Siadat SD.
    Infect Genet Evol; 2017 Oct 07; 54():330-337. PubMed ID: 28739427
    [Abstract] [Full Text] [Related]

  • 9. Predictive value of interferon-lambda gene polymorphisms for treatment response in chronic hepatitis C.
    Susser S, Herrmann E, Lange C, Hamdi N, Müller T, Berg T, Perner D, Zeuzem S, Sarrazin C.
    PLoS One; 2014 Oct 07; 9(11):e112592. PubMed ID: 25393304
    [Abstract] [Full Text] [Related]

  • 10. Interferon-λ polymorphisms and response to pegylated interferon in Iranian hepatitis C patients.
    Haj-Sheykholeslami A, Keshvari M, Sharafi H, Pouryasin A, Hemmati K, Mohammadzadehparjikolaei F.
    World J Gastroenterol; 2015 Aug 07; 21(29):8935-42. PubMed ID: 26269684
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
    Stättermayer AF, Strassl R, Maieron A, Rutter K, Stauber R, Strasser M, Beinhardt S, Datz C, Scherzer TM, Steindl-Munda P, Gschwantler M, Trauner M, Hofer H, Ferenci P.
    Aliment Pharmacol Ther; 2014 Jan 07; 39(1):104-11. PubMed ID: 24205831
    [Abstract] [Full Text] [Related]

  • 12. IFNL4 ss469415590 polymorphism contributes to treatment decisions in patients with chronic hepatitis C virus genotype 1b, but not 2a, infection.
    Wu R, Chi X, Wang X, Sun H, Lv J, Gao X, Yu G, Kong F, Xu H, Hua R, Jiang J, Sun B, Zhong J, Pan Y, Niu J.
    Infect Genet Evol; 2016 Apr 07; 39():132-140. PubMed ID: 26820907
    [Abstract] [Full Text] [Related]

  • 13. Hepatic IFNL4 expression is associated with non-response to interferon-based therapy through the regulation of basal interferon-stimulated gene expression in chronic hepatitis C patients.
    Murakawa M, Asahina Y, Kawai-Kitahata F, Nakagawa M, Nitta S, Otani S, Nagata H, Kaneko S, Asano Y, Tsunoda T, Miyoshi M, Itsui Y, Azuma S, Kakinuma S, Tanaka Y, Iijima S, Tsuchiya K, Izumi N, Tohda S, Watanabe M.
    J Med Virol; 2017 Jul 07; 89(7):1241-1247. PubMed ID: 28036111
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A single nucleotide polymorphism, rs129679860, in the IL28B locus is associated with the viral kinetics and a sustained virological response in a chronic, monoinfected hepatitis C virus genotype-1 Brazilian population treated with pegylated interferon-ribavirin.
    Ramos JA, Ramos AL, Hoffmann L, Perez Rde M, Coelho HS, Urményi TP, Silva R, Rondinelli E, Villela-Nogueira CA.
    Mem Inst Oswaldo Cruz; 2012 Nov 07; 107(7):888-92. PubMed ID: 23147144
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Interferon-λ3 polymorphisms in pegylated-interferon-α plus ribavirin therapy for genotype-2 chronic hepatitis C.
    Ishiguro H, Abe H, Seki N, Sugita T, Aida Y, Itagaki M, Sutoh S, Shimada N, Furihata T, Tsubota A, Aizawa Y.
    World J Gastroenterol; 2015 Apr 07; 21(13):3904-11. PubMed ID: 25852275
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interferon-lambda4 genetic polymorphism is associated with the therapy response for hepatitis C virus recurrence after a living donor liver transplant.
    Konishi H, Motomura T, Matsumoto Y, Harimoto N, Ikegami T, Yoshizumi T, Soejima Y, Shirabe K, Fukuhara T, Maehara Y.
    J Viral Hepat; 2014 Jun 07; 21(6):397-404. PubMed ID: 24750545
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.